
Strand Therapeutics to Present Preclinical Data on In Vivo CAR-T mRNA Platform at ASGCT 2026
Strand Therapeutics Advances In Vivo CAR-T Therapy with Programmable circRNA Platform Strand Therapeutics, a clinical-stage biotechnology company at the forefront of programmable RNA medicines, has announced the presentation of compelling…













